<!DOCTYPE html>
<html>
<head>
    <title>PressReader - The Straits Times: 2020-09-04 - SoftBank leads $136m investment in health start-up</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20200904/282291027631262" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>SoftBank leads $136m investment in health start-up</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20200904/textview" title="The Straits Times - 2020-09-04"><time>2020-09-04</time></a>
        - <span>BUSINESS</span>
        - <span role="byline"></span>
    </section>

    <p>SoftBank Group led a US$100 mil­lion (S$136 mil­lion) investment in Bio­four­mis, a soft­ware start-up that pre­dicts prob­lems for pa­tients with heart con­di­tions.</p>
    <p>SoftBank’s fi­nanc­ing came from Vi­sion Fund 2, a suc­ces­sor to its ini­tial US$100 bil­lion fund.</p>
    <p>Ex­ist­ing in­vestors EDBI of Sin­ga­pore, MassMu­tual Ven­tures, Openspace Ven­tures and Se­quoia Cap­i­tal also joined the Se­ries C round, ac­cord­ing to a state­ment.</p>
    <p>Bio­four­mis, which was founded in Sin­ga­pore be­fore it re­lo­cated its base to Bos­ton, uses ar­ti­fi­cial in­tel­li­gence (AI) to pro­vide per­son­alised care.</p>
    <p>The start-up is run­ning a pro­gram in Sin­ga­pore that mon­i­tors the con­di­tion of Covid-19 pa­tients. The strain the pan­demic is plac­ing on na­tional health­care sys­tems is driv­ing in­ter­est in tech­nol­ogy with the po­ten­tial to fa­cil­i­tate care au­to­mat­i­cally and re­motely.</p>
    <p>Bio­four­mis said it plans to use the cap­i­tal to de­velop dig­i­tal so­lu­tions across car­di­ol­ogy, res­pi­ra­tory, on­col­ogy and pain man­age­ment for pa­tients in the United States, China and Ja­pan, said chief ex­ec­u­tive Kuldeep Singh Ra­jput.</p>
    <p>“We be­lieve Bio­four­mis is a leader in us­ing AI and ma­chine learn­ing-based so­lu­tions to ad­vance dig­i­tal ther­a­peu­tics,” said SoftBank Investment Ad­vis­ers man­ag­ing part­ner Greg Moon.</p>
    <p>Vi­sion Fund 2 also has stakes in drug de­liv­ery firm Alto Phar­macy and blood-test­ing firm Kar­ius.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
